Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
Recent research indicates that indolent primary cutaneous B-cell lymphomas exhibit characteristics similar to persistent antigen reactions, lacking signs of dedifferentiation. This finding may influence future diagnostic and therapeutic strategies for this rare lymphoma subtype.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.